Protagonist Therapeutics (PTGX) Non-Current Deffered Revenue (2017 - 2025)
Protagonist Therapeutics (PTGX) posted Non-Current Deffered Revenue of $2.8 million for Q3 2025, down 48.13% sequentially from $5.4 million in Q2 2025, and down 83.11% YoY from $16.5 million in Q3 2024.
Protagonist Therapeutics (PTGX) Non-Current Deffered Revenue (2017 - 2025) Analysis & Trends
Protagonist Therapeutics has reported Non-Current Deffered Revenue for 6 years, with the latest figure at $2.8 million in Q3 2025.
- Quarterly Non-Current Deffered Revenue fell 83.11% year-over-year to $2.8 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $2.8 million (down 83.11% YoY) and the FY2024 annual result came in at $11.7 million, changed N/A from the prior year.
- Non-Current Deffered Revenue eased to $2.8 million in Q3 2025 per PTGX's latest filing, from $5.4 million in the prior quarter.
- Over five years, Non-Current Deffered Revenue peaked at $28.9 million in Q1 2024 and troughed at $2.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 220.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Protagonist Therapeutics | 10.03 Bn | 10.03 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 2.79 Mn |
| Jun 30, 2025 | 5.38 Mn |
| Mar 31, 2025 | 8.18 Mn |
| Dec 31, 2024 | 11.68 Mn |
| Sep 30, 2024 | 16.51 Mn |
| Jun 30, 2024 | 20.76 Mn |
| Mar 31, 2024 | 28.92 Mn |
| Sep 30, 2020 | 4.11 Mn |
| Jun 30, 2020 | 16.78 Mn |
| Mar 31, 2020 | 20.42 Mn |
| Dec 31, 2019 | 23.79 Mn |
| Sep 30, 2019 | 22.20 Mn |
| Jun 30, 2019 | 23.85 Mn |
| Dec 31, 2018 | 799,000.00 |
| Sep 30, 2018 | 797,000.00 |
| Jun 30, 2018 | 793,000.00 |
| Mar 31, 2018 | 694,000.00 |
| Dec 31, 2017 | 547,000.00 |
| Sep 30, 2017 | 332,000.00 |
| Jun 30, 2017 | 83,000.00 |